Merck & Co., Inc.'s Net Worth

$1.18 Billion

Estimate Recalculated Jul 24, 2024 04:24PM EST

Who is Merck & Co., Inc.?

Merck & Co., Inc. has an estimated net worth of $1.18 Billion. This is based on reported shares across multiple companies, which include Pandion Therapeutics, Inc., OPGEN INC, BeiGene, Ltd., Organon & Co., ARQULE INC, NGM BIOPHARMACEUTICALS INC, SUTRO BIOPHARMA INC, and Menlo Therapeutics Inc..

SEC CIK

Merck & Co., Inc.'s CIK is 0000310158

Past Insider Trading and Trends

2016 was Merck & Co., Inc.'s most active year for acquiring shares with 8 total transactions. Merck & Co., Inc.'s most active month to acquire stocks was the month of January. 2016 was Merck & Co., Inc.'s most active year for disposing of shares, totalling 2 transactions. Merck & Co., Inc.'s most active month to dispose stocks was the month of January. 2019 saw Merck & Co., Inc. paying a total of $65,946,928.00 for 12,955,016 shares, this is the most they've acquired in one year. In 2021 Merck & Co., Inc. cashed out on 253,516,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

OPGEN INC (OPGN) Snapshot price: $0.3172

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+102.07%
2.73M
—
—
5.41M
Jun 27
Form 4
+81.13%
1.2M
—
—
2.68M
May 19
Form 3
—
0
—
—
0
No matching records found

BeiGene, Ltd. (BGNE) Snapshot price: $153.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
31.59M
—
—
31.59M
Feb 8
Form 3
—
0
—
—
0
No matching records found

Organon & Co. (OGN) Snapshot price: $17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-253.52M
—
—
0
Jun 2
Form 3
—
0
—
—
0
No matching records found

Pandion Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

ARQULE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found